NCT01735617View on ClinicalTrials.gov

Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Endocrine DiseaseAdrenal InsufficiencyCongenital Adrenal Hyperplasia
Interventions
DRUG

Hydrocortisone Modified Release Capsules

Patients with congenital adrenal hyperplasia standardised on conventional therapy is enrolled onto the study and treatment is switched to Chronocort, initially for pharmacokinetic assessment followed by longer-term biochemical and efficacy assessment

Trial Locations (1)

20892-1932

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Neurocrine UK Limited

INDUSTRY

NCT01735617 - Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH | Biotech Hunter | Biotech Hunter